Dong Lyu
Directeur/Membre du Conseil chez GENOR BIOPHARMA HOLDINGS LIMITED
Postes actifs de Dong Lyu
Sociétés | Poste | Début | Fin |
---|---|---|---|
GENOR BIOPHARMA HOLDINGS LIMITED | Directeur/Membre du Conseil | 02/11/2021 | - |
LUYE PHARMA GROUP LTD. | Directeur/Membre du Conseil | 06/12/2023 | - |
Zhuhai Hillhouse Investment Management Holding Co. Ltd. | Corporate Officer/Principal | 30/09/2020 | - |
Zhuhai Gao Ling Equity Investment Management Co. Ltd. | Corporate Officer/Principal | 01/09/2020 | - |
Historique de carrière de Dong Lyu
Anciens postes connus de Dong Lyu
Sociétés | Poste | Début | Fin |
---|---|---|---|
JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Directeur/Membre du Conseil | 30/11/2020 | 31/08/2023 |
CLOVER BIOPHARMACEUTICALS, LTD. | Directeur/Membre du Conseil | 16/03/2021 | 28/10/2022 |
KEYMED BIOSCIENCES INC. | Directeur/Membre du Conseil | 03/03/2021 | 29/03/2022 |
Pag Growth Zhuhai Holding Investment Management Co. Ltd. | Corporate Officer/Principal | 01/09/2016 | 01/09/2020 |
Shanghai Panxin Equity Investment Management Co. Ltd. | Corporate Officer/Principal | 01/07/2011 | 01/07/2016 |
░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Formation de Dong Lyu
Peking University | Graduate Degree |
China Pharmaceutical University | Doctorate Degree |
Beijing Medical University | Undergraduate Degree |
Statistiques
Internationale
Chine | 11 |
Îles Cayman | 3 |
Hong Kong | 2 |
Opérationnelle
Director/Board Member | 6 |
Corporate Officer/Principal | 4 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 7 |
Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 5 |
---|---|
LUYE PHARMA GROUP LTD. | Health Technology |
GENOR BIOPHARMA HOLDINGS LIMITED | Health Technology |
KEYMED BIOSCIENCES INC. | Health Technology |
JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Health Technology |
CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
Entreprise privées | 5 |
---|---|
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Health Technology |
Shanghai Panxin Equity Investment Management Co. Ltd. | |
Pag Growth Zhuhai Holding Investment Management Co. Ltd. | |
Zhuhai Hillhouse Investment Management Holding Co. Ltd. | |
Zhuhai Gao Ling Equity Investment Management Co. Ltd. |